Letters and drug alerts sent to healthcare professionals in February 2019

Source:
GOV UK
Publisher:
Medicines and Healthcare products Regulatory Agency
Publication date:
21 March 2019

Abstract

Letters were sent about Vyxeos (cytarabine, daunorubicin) and Ozurdex 700 micrograms intravitreal implant (dexamethasone).